Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
FTC tells Novo that Metsera offer may violate US merger law
The proposed purchase of Metsera by Novo "may violate the procedural provisions" of the Hart-Scott-Rodino Act, an FTC official wrote.
Eric Sagonowsky
Nov 5, 2025 4:26pm
Celltrion pens $744M pact for 2 preclinical autoimmune drugs
Nov 4, 2025 6:15am
Roche signs $2B pact to pilot Manifold's shuttles to the brain
Nov 3, 2025 8:45am
Neurocrine pens $880M pact with TransThera for immunology target
Nov 3, 2025 5:42am
BMS removes 2 clinical programs from pipeline
Oct 30, 2025 1:14pm
Regeneron pledges $1B+ for ModeX multispecific antibodies
Oct 29, 2025 11:04am
